Skip to content
10-K/A

Annual Report

NUNZIA PHARMACEUTICAL COMPANY

0001683168-22-002045

← back to feed
Filed
Mar 29, 2022 12:00 AM ET
Period of report
Amendment. Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2020 · Mar 29, 2022 434.12M sh
Operating Cash Flow restated FY 2020 · Dec 31, 2020 −$23K
Operating Cash Flow FY 2020 · Dec 31, 2019 −$3.8K
Stockholders Equity restated FY 2020 · Dec 31, 2020 −$59.4K
Stockholders Equity FY 2020 · Dec 31, 2019 −$22.58K
Current Liabilities FY 2020 · Dec 31, 2020 $36.4K
Current Liabilities FY 2020 · Dec 31, 2019 $22.58K
Total Liabilities FY 2020 · Dec 31, 2020 $59.4K
Total Liabilities FY 2020 · Dec 31, 2019 $22.58K
Current Assets FY 2020 · Dec 31, 2020 $0
Current Assets FY 2020 · Dec 31, 2019 $0
Total Assets FY 2020 · Dec 31, 2020 $0
Total Assets FY 2020 · Dec 31, 2019 $0
Eps Basic FY 2020 · Dec 31, 2020 −$0.35
Eps Basic FY 2020 · Dec 31, 2019 $0.00
Sga Expense restated FY 2020 · Dec 31, 2020 $39.33K
Sga Expense FY 2020 · Dec 31, 2019 $33.64K
Net Income restated FY 2020 · Dec 31, 2020 −$101.02M
Net Income FY 2020 · Dec 31, 2019 −$33.64K
Operating Income restated FY 2020 · Dec 31, 2020 −$39.33K
Operating Income FY 2020 · Dec 31, 2019 −$33.64K
Revenue FY 2020 · Dec 31, 2020 $0
Revenue FY 2020 · Dec 31, 2019 $0